MMP14 and lung carcinoma: To summarize, the current study demonstrated that BSP promotes MMP‐14‐dependent resistance to anoikis in human lung cancer cells by inhibiting the synthesis of miR‐150‐5p and activating the ERK signalling pathway (Figure 8).